NEWTON, Mass.--(BUSINESS WIRE)--May 8, 2006--Pro-Pharmaceuticals, Inc. (Amex: PRW - News), a developer of novel carbohydrate therapeutic compounds, today announced that it has retained James T. Gourzis, M.D., Ph.D., on a consulting basis, to provide clinical management and strategic development of its Europe-based Phase III colorectal cancer trial. Dr. Hana Chen-Walden is the lead regulatory consultant and medical monitor for the study.
